Vitamin D(3) enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk

BACKGROUND: Vitamin D(3) (VitD) deficiency is linked to increased incidence and worse survival in bladder cancer (BCa). In addition to cystectomy, patients are treated with cisplatin‐based chemotherapy, however 30%‐50% of patients do not benefit from this treatment. The effects of VitD deficiency on...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunch, Brittany L., Ma, Yingyu, Attwood, Kristopher, Amable, Lauren, Luo, Wei, Morrison, Carl, Guru, Khurshid A., Woloszynska‐Read, Anna, Hershberger, Pamela A., Trump, Donald L., Johnson, Candace S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537042/
https://www.ncbi.nlm.nih.gov/pubmed/30972950
http://dx.doi.org/10.1002/cam4.2119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537042/
https://www.ncbi.nlm.nih.gov/pubmed/30972950
http://dx.doi.org/10.1002/cam4.2119

Ejemplares similares